org placeholder image

Marcus Krause

Head of Bimekizumab Launch Strategy - Us Rheumatology at UCB

  • LinkedIn

Email Email: m****@ucb.com

phone noPhone Number: (***)-***-****

map
UCB

UCB

  • description Description
    UCB Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients lives by ...

    Read More

  • Employees count Employees 5001-10000
  • Revenue Revenue 1 Billion and Over
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

UCB Org Chart and Mapping

Tina Bettina

Chief Executive Officer

VP-Level
Employees

Kymberly Lee

Project Statistical Programmer

Miguel Gonzalez

Field Reimbursement Manager

Carmen Cole

Quality Assurance Specialist

Mike Sagar

Immunology Specialty District Manager - Mid South

CRCR Matthew Curry

Vice President, Business Development - Healthcare

Jason Morgan

Regulatory Science Lead

Frequently Asked Questions Regarding Marcus Krause

Answer: Marcus Krause works for UCB as Head of Bimekizumab Launch Strategy - Us Rheumatology

Answer: Marcus Krause’s role in UCB is Head of Bimekizumab Launch Strategy - Us Rheumatology

Answer: Marcus Krause's email address is m***@gmail.com

Answer: Marcus Krause's business email address is m****@ucb.com

Answer: Marcus Krause’s direct phone number is (***)-***-****

Answer: Marcus Krause works in the industry of: Pharmaceuticals

Answer: Marcus Krause works UCB located at 60 Allée De La Recherche, Brussels, Brussels Capital, 1070, Belgium,

Answer: UCB's Head of Bimekizumab Launch Strategy - Us Rheumatology is Marcus Krause

Answer: Marcus Krause contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@ucb.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access